Researchers of VHIR and IRBLleida validate the new antitumor agent ABTL0812 as a new therapeutic strategy to fight against endometrial cancer
August 5, 2020 6:21 pmCategorised in:
This post was written by ondeuev
Categorised in:
This post was written by ondeuev